CannaSoul Analytics ^{For Profit}

The Cannasoul Group is a drug discovery company that focuses on developing therapeutics derived from natural compounds, with a special emphasis on cannabis. The company was founded by Prof. Dedi Meiri from the Technion – Israel Institute of Technology and is supported by a team of experts in analytical chemistry, bioanalytics, extraction, isolation, and pre-clinical and clinical studies. Cannasoul offers a range of services, including analytics development by demand, IP licensing, and clinical and pre-clinical trials. The company serves as a cannabis innovation, research, and technology incubator, forming strategic partnerships with leaders across the globe. Contact info: P.O.B 3150, 5 Tarshish St. Caesarea, Israel. Phone: +972 (0)73 3989150. Fax: +972 (0)4 6750646. E-mail: info@cannasoul.co.il.